ArticleMagyar onkologia2026
[rare subtype of kidney cancer - Pigmented microcystic chromophobe carcinoma].
Article in Magyar onkologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimChromophobe renal cell carcinoma (chRCC) is a morphologically heterogeneous tumor type, with one of its rarest forms being pigmented microcystic chromophobe carcinoma.
methodsIn our paper, we present the case of a 68-year-old man, in whom imaging studies identified a 32 mm kidney tumor.
resultsThe tumor was surgically removed, and pathological analysis revealed a cystic tumor with unusual morphology, composed of eosinophilic cells. Brown pigment and hemorrhage were present in the lumen of the cysts. Immunohistochemically, the tumor showed diffuse CD117, PAX8, and E-cadherin expression, with focal positivity for CK7 and CD10. GATA3, MelanA, HMB45, cathepsin K, CK20, chromogranin A, and synaptophysin reactions were negative. Chromosome 17 monosomy could not be detected using double-labeled HER2/cen17 chromogenic in situ hybridization. The patient recovered well after the operation and is currently under oncological care.
conclusionsTo the best of our knowledge, this is the first documented case of pigmented microcystic chromophobe carcinoma diagnosed in Hungary. The aim of this paper is primarily to raise awareness, and in the course of our work, we will review the morphological subtypes of chRCC and the differential diagnostic entities.
Indexed as
Identifiers
41819063PMC12990078What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.